Moderna and Merck are now testing the cancer vaccine in addition to Merck’s Keytruda in patients with bladder cancer and kidney cancer, RBC Capital Markets analyst Luca Issi said in a report. Patients will receive either Keytruda or Keytruda plus the cancer...